Treace Medical Concepts announced the successful first surgical use of its HyperPlate™ XM Dynamic Compression Locking Implant, designed for midfoot and hindfoot fusion procedures. This new implant enhances the existing SpeedPlate® platform by offering rapid insertion, dynamic compression, and improved stability with FastPitch® locking screws. The HyperPlate™ XM system, complemented by new sterile instruments, aims to expand Treace's reach in foot and ankle surgeries and is expected to be fully commercialized by Q3 2026. This innovation supports Treace's strategy to broaden its surgical solutions and increase procedural adoption among surgeons.
The phase III ENDURANCE trial showed that two years of lenalidomide maintenance therapy offers the same long-term survival benefit as indefinite treatment for patients with standard-risk multiple myeloma who are not transplant candidates. After nearl...
Lowey Dannenberg, P.C. is investigating Hims & Hers Health, Inc. for allegedly sharing sensitive user health data, including medical histories and mental health info, with third parties without proper consent. This raises concerns about violations of...
Digital agency 9thCO completed a major digital transformation for DNRS, moving from a fragmented WordPress setup to a unified composable architecture. This upgrade centralizes user management, integrates key business tools like CRM and scheduling, an...
Willis Towers Watson, a global advisory firm, is poised for growth with a 25.3% potential stock upside, driven by new initiatives like KwantSure, a digital insurance sales channel for subcontractors, and a Geospatial Mortality Model to improve pensio...
AngioDynamics reported an 8% revenue increase to $86.6 million in Q4, driven by a 16.7% sales rise in its Med Tech division, notably from NanoKnife and AlphaVac products. H.C. Wainwright raised the price target from $16 to $19 and maintained a Buy ra...
